Inventor

MESTAN JUERGEN

DE12 patents

⚠️ This page may combine multiple inventors who share the name “MESTAN JUERGEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NOVARTIS AG

6 patents

US7122547B1Oct 17, 2006

Anthranilic acid amides and the use thereof as medicaments

NOVARTIS AG79 citations97

US6878720B2Apr 12, 2005

VEGF receptor tyrosine kinase inhibitors

NOVARTIS AG50 citations96

US6448277B2Sep 10, 2002

VEGF receptor tyrosine kinase inhibitors

NOVARTIS AG64 citations96

US5935976AAug 10, 1999

Antiviral ethers of aspartate protease substrate isosteres

NOVARTIS AG18 citations91

US7767688B2Aug 3, 2010

Combination of pyrimidylaminobenzamide compounds and imatinib for treating gastrointestinal stromal tumours

NOVARTIS AG10 citations82

US7666874B2Feb 23, 2010

Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome

NOVARTIS AG6 citations73

ALLAND LEILA

2 patents

US8653093B2Feb 18, 2014

Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases

ALLAND LEILA7 citations80

US8673930B2Mar 18, 2014

Pyrimidylaminobenzamide derivatives for systemic mastocytosis

ALLAND LEILA6 citations69

CIBA GEIGY AG

1 patent

US5807891ASep 15, 1998

Antiviral ethers of aspartate protease substrate isosteres

CIBA GEIGY AG54 citations94

SCHERING AG

1 patent

US7002022B2Feb 21, 2006

N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF

SCHERING AG24 citations92

CIBA GEIGY CORP

1 patent

US5663200ASep 2, 1997

Antiviral ethers of aspartate protease substrate isosteres

CIBA GEIGY CORP28 citations91

MANLEY PAUL W

1 patent

US8093259B2Jan 10, 2012

4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]-benzamide for treatment of melanoma

MANLEY PAUL W6 citations80